Search Results - "STAHL, M. M. S"

The metabolic syndrome and schizophrenia by Meyer, J. M., Stahl, S. M.

“…Objective:  To summarize the accumulated data on metabolic syndrome prevalence in patients with schizophrenia, examine evidence for a biological contribution…”
Get full text

Which comes first: atypical antipsychotic treatment or cardiometabolic risk? by Stahl, S. M., Mignon, L., Meyer, J. M.

“…Objective:  To provide an overview for practicing clinicians on the pharmacological basis of cardiometabolic risk induced by antipsychotic drugs in patients…”
Get full text

Pharmacological treatment of negative symptoms of schizophrenia: therapeutic opportunity or Cul-de-sac? by Buckley, P. F., Stahl, S. M.

“…Objective:  Negative symptoms of schizophrenia are debilitating and they contribute to poor outcome in schizophrenia. Initial enthusiasm that second‐generation…”
Get full text

Negative symptoms of schizophrenia: a problem that will not go away by Stahl, S. M., Buckley, P. F.

“…Objective:  Negative symptoms of schizophrenia are a common, enduring, and debilitating component of the psychopathology of schizophrenia. Although efforts…”
Get full text

Body mass index at the time of diagnosis and the risk of advanced stages and poorly differentiated cancers of the breast: findings from a case-series study by Stark, A, Stahl, M.S, Kirchner, H.L, Krum, S, Prichard, J, Evans, J

“…Introduction: Obesity is a risk factor for postmenopausal breast cancer and is independently associated with shorter disease-free and overall survival…”
Get full text

Dopamine system stabilizers, aripiprazole, and the next generation of antipsychotics, part 1, "Goldilocks" actions at dopamine receptors by Stahl, S M

“…Dopamine system stabilizers are a potential new class of antipsychotic agents without motor side effects. All known effective antipsychotics act at D2…”
Get full text

A critical review of atypical antipsychotic utilization: comparing monotherapy with polypharmacy and augmentation by Stahl, S M, Grady, M M

“…The atypical antipsychotics risperidone, olanzapine, quetiapine, ziprasidone, and aripiprazole have become first-line treatment for schizophrenia because they…”
Get more information

Dopamine system stabilizers, aripiprazole, and the next generation of antipsychotics, part 2. Illustrating their mechanism of action by STAHL, Stephen M

Get full text

Psychotherapy as an epigenetic 'drug': psychiatric therapeutics target symptoms linked to malfunctioning brain circuits with psychotherapy as well as with drugs by Stahl, S. M.

“…Summary What is known and Objective:  Psychotherapy has traditionally competed with psychopharmacology. As drugs have become the more dominant treatment in…”
Get full text

Antipsychotic polypharmacy, Part 1 : Therapeutic option or dirty little secret? by STAHL, S. M

“…Antipsychotic polypharmacy is a surprisingly frequent occurrence that can be both justified and unjustifed, depending on how it is used. To the extent that…”
Get full text

Antipsychotic polypharmacy, Part 2 : Tips on use and misuse by STAHL, S. M

Get full text

Searching for perfect sleep: the continuing evolution of GABAA receptor modulators as hypnotics by Nutt, David J, Stahl, S M

“…The non-benzodiazepine GABAA receptor modulators (‘Z-drugs’) — zaleplon, zolpidem, zopiclone and eszopiclone — have become the accepted treatments for insomnia…”
Get full text

Neuropharmacology of obesity : My receptors made me eat it by STAHL, S. M

“…Body weight is regulated by complex interrelationships between central and peripheral factors. Satiety, appetite, and craving are CNS drives, whereas…”
Get full text

Urethral Sphincter Mechanism Incompetence in 163 Neutered Female Dogs: Diagnosis, Treatment, and Relationship of Weight and Age at Neuter to Development of Disease by Byron, J.K., Taylor, K.H., Phillips, G.S., Stahl, M.S.

“…Background Urethral sphincter mechanism incompetence (USMI) is the most common cause of urinary incontinence in neutered bitches and is most common in dogs…”
Get full text

A double-blind, placebo-controlled study comparing the effects of sertraline versus amitriptyline in the treatment of major depression by LYDIARD, R. B, STAHL, S. M, HERTZMAN, M, HARRISON, W. M

“…This study was designed to compare the efficacy, safety, tolerability profiles, and effects on quality of life of the serotonin selective reuptake inhibitor…”
Get full text

Structural imaging of schizophrenia: is the modern psychiatrist becoming a 'disease scene investigator?' by Stahl, S. M.

“…Perlini et al provide an overview of how brain images can be read, explaining how structural abnormalities are being investigated in schizophrenia. This…”
Get full text

The psychopharmacology of sex, Part 1: Neurotransmitters and the 3 phases of the human sexual response by Stahl, S M

Get full text

Innovative solutions to novel drug development in mental health by Insel, T R, Voon, V, Nye, J S, Brown, V J, Altevogt, B M, Bullmore, E T, Goodwin, G M, Howard, R J, Kupfer, D J, Malloch, G, Marston, H M, Nutt, D J, Robbins, T W, Stahl, S M, Tricklebank, M D, Williams, J H, Sahakian, B J

“…There are many new advances in neuroscience and mental health which should lead to a greater understanding of the neurobiological dysfunction in…”
Get full text

Structural imaging of schizophrenia: is the modern psychiatrist becoming a 'disease scene investigator?': an editorial comment to Perlini C, Bellani M, Brambilla P. 'Structural imaging techniques in schizophrenia' by Stahl, S M

Get full text

The pharmacodynamic effects of combined administration of flibanserin and alcohol by Stevens, D. M., Weems, J. M., Brown, L., Barbour, K. A., Stahl, S. M.

“…Summary What is known and objective Flibanserin is a serotonin 5‐HT1A agonist and 5‐HT2A antagonist approved for the treatment of acquired, generalized…”
Get full text